trehalose has been researched along with Acute Liver Injury, Drug-Induced in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, RF; Gong, ZG; Wang, JH; Wang, L; Wang, XY | 1 |
| Chand, M; Dhaundiyal, A; Jena, SK; Samal, SK; Sangamwar, AT; Sonvane, B | 1 |
2 other study(ies) available for trehalose and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Trehalose prevents cadmium-induced hepatotoxicity by blocking Nrf2 pathway, restoring autophagy and inhibiting apoptosis.
Topics: Animals; Apoptosis; Autophagic Cell Death; Cadmium; Chemical and Drug Induced Liver Injury; Liver; Male; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Trehalose | 2019 |
Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
Topics: Administration, Oral; Amines; Animals; Biological Availability; Chemical and Drug Induced Liver Injury; Cryoprotective Agents; Drug Carriers; Drug Compounding; Drug Stability; Estrogen Antagonists; Female; Freeze Drying; Hydrogen-Ion Concentration; Nanoparticles; Nanotechnology; Particle Size; Rats, Sprague-Dawley; Solubility; Solvents; Surface Properties; Surface-Active Agents; Tamoxifen; Technology, Pharmaceutical; Thioctic Acid; Trehalose | 2016 |